Jacob Kilstein

Argus’ Jacob Kilstein believes that robust trends in housing starts and China demand, along with the sale of the struggling Cellulose Fibers business could prove to be future growth drivers for Weyerhaeuser Co (NYSE: WY) Kilstein reiterated a Buy rating on the company, with a price target...

Argus’ Jacob Kilstein believes Zoetis Inc (NYSE: ZTS) has been benefiting from a “lack of generic competition in the animal drug space.” Kilstein maintains a Buy rating on the company, while raising the price target from $54 to $58. Benefiting From Animal Drug Space The analyst...

Argus reiterated its Buy rating on Allstate Corp (NYSE: ALL) and raised its price target by $2 to $76 after the company improved its combined ratio in the first half of 2016, a sign of improving profitability. Rating And Expectations Also, Allstate is becoming shareholder friendly, as it recently...

Although Regency Centers Corp (NYSE: REG) continued to report robust operating results, the stock is currently trading at a premium to peers and above its five-year historical average for price/FFO. Argus’ Jacob Kilstein maintains a Hold rating on the company, while stating the stock appeared...

On August 22, Pfizer Inc. (NYSE: PFE) announced it had entered into an agreement to acquire Medivation Inc (NASDAQ: MDVN) for almost $14 billion or $81.50 per shares. Argus’ Jacob Kilstein maintains a Buy rating on Pfizer with a price target of $39. The Acquisition Kilstein mentioned the...

Argus has maintained its Hold rating on Ventas, Inc. (NYSE: VTR) as it expects growth to be constrained in the near term by asset sales and dilutive equity issuance, despite having opportunities in the $1 trillion senior housing and healthcare real estate market. However, the brokerage said shares...

Shares of Host Hotels and Resorts Inc (NYSE: HST) are expected to benefit from higher earnings, share repurchases and dividend hikes in the coming quarters, Argus’s Jacob Kilstein said in a report. He maintained a Buy rating on the company, while raising the price target from $19 to $21....

Argus maintains its Buy rating on Quintiles Transnational Holdings Inc (NYSE: Q) shares. The brokerage also lifted its price target from $75 to $85. The move comes after the company delivered better-than-estimated second-quarter results and an increased outlook on July 27. Analysts Jacob Kilstein...

Argus reiterated its Buy rating on American Tower Corp (NYSE: AMT) shares. The brokerage boosted the price objective from $120 to $130 citing expected increased demand from mobile data usage. Argus analysts, led by Jacob Kilstein, expect American Tower to gain from a yearly increase in lease rate...

Ventas, Inc. (NYSE: VTR) shares have performed strongly over the past year and appear fully valued at present. However, Argus’ Jacob Kilstein prefers to wait for a non-fundamental pullback to become more constructive on the stock. Kilstein initiated coverage of the company with a Hold rating...

Perrigo Company plc Ordinary Shares (NYSE: PRGO) shares have come under significant pressure after CEO Papa stepped down and the company reduced its guidance. Argus’ Jacob Kilstein downgraded the rating for Perrigo to Hold, citing the “resulting uncertainty over the company’s...

Argus analysts Jacob Kilstein and Casey Meyers have boosted the price target of Sun Life Financial Inc (NYSE: SLF) shares to $37.00 from $35.00. The analysts retained their rating of Buy on the stock. The brokerage thinks that its revised target implies a multiple of 12.8X to its 2016 EPS estimate...